Results 211 to 220 of about 358,200 (372)

Paederus Dermatitis Acquired in the Gambia. [PDF]

Am J Trop Med Hyg
Ogunbiyi O, Mawani NM, Walker SL.
europepmc   +1 more source

Symbiotic options for the conquest of land.

Trends in Ecology & Evolution, 2015
K. Field, Silvia Pressel, J. Duckett, William R. Rimington, M. Bidartondo   +4 more
semanticscholar   +1 more source

Interaction In Critical Systems : Conquests And Challenges

, 2007
Guimarães, Baranauskas M.C.C., E Martins   +2 more
openalex   +1 more source

THE HISTORY OF THE SYRIAN CITY OF MANBIJ FROM THE ISLAMIC CONQUEST TO THE OTTOMAN CONQUEST

Abdullah Şeyhoğlu, Metin Şerifoğlu
openalex   +2 more sources

The Paths of the European Conquest of the Atlantic: Osteological Evidence of Warfare and Violence in Gran Canaria (XV Century)

, 2015
Jonathan Santana, Javier Velasco Vázquez, Amelia Rodríguez Rodríguez, M. C. González‐Marrero, Teresa Delgado‐Darias   +4 more
openalex   +2 more sources

'What remains behind': Hellenism and Romanitas in Christian Egypt after the Arab conquest [PDF]

, 2009
Papaconstantinou, Arietta
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Optimizing quarantine in pandemic control: a multi-stage SEIQR modeling approach to COVID-19 transmission dynamics. [PDF]

BMC Infect Dis
Siddig NH, Al-Essa LA.
europepmc   +1 more source

The Conquest of Disease through Animal Experimentation . By J. P. Warbasse, M.D. Pp. xii + 176. New York, D. Appleton & Co. 1910.

, 1910
Steven J. Holmes
openalex   +2 more sources

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source